Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 36 Show results per page	View Search Criteria \| Help With Results


1.		Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care, Treatment				Active				18 and over				Other				seromprotocol NCT00307606

Last Modified: 6/10/2008 First Published: 7/1/2002


2.		Phase II/III Randomized Study of Ginger for Chemotherapy-Related Nausea in Patients With Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Supportive care				Active				18 and over				NCI				URCC-U1902 URCC-0114, NCI-5857, NCI-P02-0223, NCT00040742

Last Modified: 12/5/2007 First Published: 4/1/1999


3.		Phase III Randomized Study of Dexamethasone Versus Prednisolone During Induction Therapy and Prolonged Versus Conventional Duration Asparaginase During Consolidation and Late Intensification Therapy in Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 18				Other				EORTC-58951 NCT00003728

Last Modified: 6/17/2008 First Published: 11/13/2006


4.		Phase III Randomized Study of Pegasparaginase Verus E. coli Asparaginase With Combination Chemotherapy in Children With Newly Diagnosed Acute Lymphoblastic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				1 to 17				NCI				DFCI-05001 NCT00400946

Last Modified: 9/18/2008 First Published: 11/6/2007


5.		Phase III Partially Randomized Study of Risk-Directed Therapy Comprising a Modified P9407 Chemotherapy Backbone With or Without Lestaurtinib in Infants With Newly Diagnosed Acute Lymphoblastic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Treatment				Active				Under 1 at diagnosis				NCI				COG-AALL0631 AALL0631, NCT00557193


6.		Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Diagnostic, Treatment				Active				18 to 80				Other				PETAL trial EudraCT-Number 2006-001641-33, Krebshilfe Grant 107592, NCT00554164


7.		Corticosteroids for Cancer Pain

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				18 and over				Other				OPI 07-005 Eudra CT nr 2007-005617-19, NCT00676936

Last Modified: 6/2/2008 First Published: 2/5/2008


8.		Phase I/II Study of Cytoreduction Therapy Comprising High-Dose Cytarabine and Mitoxantrone Hydrochloride in Patients With Juvenile Myelomonocytic Leukemia Undergoing a Second Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Residual Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Juvenile				NCI				UMN-1999LS032 UMN-1999LS032, UMN-MT1999-08, NCT00609739

Last Modified: 7/13/2007 First Published: 1/26/2003


9.		Phase II Study of Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematologic Malignancy or Aplastic Anemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				5 to 70				NCI				RPCI-RP-0105 NCT00053989, RP 01-05

Last Modified: 9/19/2008 First Published: 3/24/2003


10.		Phase II Pilot Study of Rituximab Added to the Induction and Consolidation Phases and Rasburicase Added to the Reduction Phase in Children With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma Treated With LMB/FAB Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				1 to 29				NCI				COG-ANHL01P1 NCT00057811, ANHL01P1

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute